AXGN Logo

AxoGen, Inc. (AXGN) 

NASDAQ
Market Cap
$649.78M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
563 of 966
Rank in Industry
68 of 120

Largest Insider Buys in Sector

AXGN Stock Price History Chart

AXGN Stock Performance

About AxoGen, Inc.

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Insider Activity of AxoGen, Inc.

Over the last 12 months, insiders at AxoGen, Inc. have bought $0 and sold $1.07M worth of AxoGen, Inc. stock.

On average, over the past 5 years, insiders at AxoGen, Inc. have bought $188,940 and sold $2.2M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,000 shares for transaction amount of $62,240 was made by Wendell Amy McBride (director) on 2023‑09‑06.

List of Insider Buy and Sell Transactions, AxoGen, Inc.

2024-03-21SaleCEO
39,280
0.091%
$7.68$301,670+18.90%
2024-03-21SaleChief Innovation Officer
4,578
0.0106%
$7.68$35,159+18.90%
2024-03-21SaleChief R&D Officer
6,881
0.0159%
$7.68$52,846+18.90%
2024-03-21SaleVP Operations
6,033
0.014%
$7.68$46,333+18.90%
2024-03-07Saledirector
25,000
0.0581%
$9.00$225,000-8.76%
2024-03-07SaleVP Operations
36,310
0.0826%
$8.81$319,891-8.76%
2023-12-11SaleEVP & Chief Financial Officer
12,500
0.0291%
$7.50$93,809+17.24%
2023-09-06Purchasedirector
10,000
0.0235%
$6.22$62,240+16.26%
2023-08-23Purchasedirector
10,000
0.0234%
$6.56$65,600+7.44%
2023-08-16Purchasedirector
10,000
0.0252%
$6.11$61,100+23.36%
2023-06-01Saledirector
41,980
0.0994%
$8.71$365,780-18.63%
2023-05-23Saledirector
7,468
0.0176%
$9.23$68,899-21.55%
2023-02-01SaleEVP & Chief Financial Officer
14,550
0.0348%
$9.36$136,188-11.25%
2023-01-31SaleEVP & Chief Financial Officer
14,320
0.0343%
$9.55$136,756-12.94%
2023-01-30SaleEVP & Chief Financial Officer
14,111
0.0334%
$9.69$136,736-15.26%
2023-01-27SaleEVP & Chief Financial Officer
20,940
0.0495%
$10.16$212,750-19.29%
2022-11-16SaleEVP & Chief Financial Officer
10,649
0.027%
$11.88$126,510-24.25%
2022-11-14Saledirector
13,000
0.0339%
$12.74$165,620-27.03%
2022-11-08Saledirector
13,000
0.0337%
$12.50$162,500-25.66%
2022-08-10Sale
8,886
0.0204%
$9.70$86,159-4.15%

Insider Historical Profitability

12.63%
Zaderej Karen L.CEO
1124565
2.5553%
$14.7798+15.63%
Freitag Gregory Genedirector
271594
0.6171%
$14.77612+24.07%
DeVinney Erick WayneChief Innovation Officer
165661
0.3764%
$14.7703
MARIANI PETER JEVP & Chief Financial Officer
63603
0.1445%
$14.7719+19.13%
Scopelianos AngeloChief R&D Officer
52999
0.1204%
$14.7702
Donovan Michael PatrickVP Operations
37992
0.0863%
$14.77010
Essex Woodlands Fund IX, L.P.10 percent owner
3711111
8.4328%
$14.7701
Flynn James E10 percent owner
3000000
6.8169%
$14.7706
Mandato Joseph Mdirector
1226773
2.7876%
$14.7714+61.29%
Hopfenspirger Larry10 percent owner
426066
0.9681%
$14.7710
Gold Mark Stephendirector
348761
0.7925%
$14.7751+18.2%
Harper John Frederickdirector
214094
0.4865%
$14.7720+16.33%
Engels John PVP
98425
0.2237%
$14.7710+19.13%
Wendell Amy McBridedirector
80342
0.1826%
$14.7740<0.0001%
NEELS GUIDO Jdirector
68259
0.1551%
$14.7711
MCCARREY SHAWN FSVP Sales
33057
0.0751%
$14.7731+6.48%
Hansen David KVP Finance & Treasurer
25588
0.0581%
$14.7701
Johnston Lee Robert JrChief Finacial Officer
25000
0.0568%
$14.7730+32.93%
Rudelius Robert Jamesdirector
23273
0.0529%
$14.7731
Blackford Quentin S.director
15535
0.0353%
$14.7720<0.0001%
Schiaparelli Jill FSVP, Bus. Strategy&Marketing
12750
0.029%
$14.7760+14.98%
Friedman Mark LouisVP,Regulatory & Quality
11124
0.0253%
$14.7702
Burke William P. Mr.director
10000
0.0227%
$14.7710
Billet IsabelleChief Strategy and BD Officer
9496
0.0216%
$14.7711<0.0001%
MARTINEZ MARIA D.Chief Human Resources Officer
2932
0.0067%
$14.7712<0.0001%
Leach KevinVice President Marketing
2000
0.0045%
$14.7710+19.13%
Grooms Jamie Markdirector
372
0.0008%
$14.77011

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Arrowmark Colorado Holdings Llc$38.14M10.824.73M-8.26%-$3.43M0.1
BlackRock$26.08M7.43.23M-3.31%-$892,267.67<0.01
Morgan Stanley$25.67M7.283.18M+3.18%+$791,997.89<0.01
Soleus Capital Management, L.P.$25.06M7.113.11M+19.65%+$4.12M0.1
The Vanguard Group$19.46M5.522.41M-2.19%-$436,530.51<0.0001
Perceptive Advisors$12.54M3.561.55M+92.23%+$6.02M0.01
Millennium Management LLC$10.62M3.011.32M-11.59%-$1.39M0.01
DAFNA Capital Management, LLC$7.55M2.14935,8940%+$00.18
Geode Capital Management$7.51M2.13930,810+3.85%+$278,245.86<0.01
State Street$6.45M1.83799,051+0.88%+$56,199.48<0.0001
Silvercrest Asset Management Group Inc$6.38M1.81790,647+4.55%+$277,599.920.04
Tocqueville Asset Management$6.21M1.76769,9000%+$00.1
First Light Asset Management$6.18M1.75765,886+177%+$3.95M0.52
Dimensional Fund Advisors$5.76M1.63714,247+23.3%+$1.09M<0.01
Prudential Financial$5.28M1.5654,585+367.28%+$4.15M0.01
D. E. Shaw & Co.$4.89M1.39606,555-0.73%-$35,774.310.01
Deutsche Bank$4.68M1.33579,376+0.13%+$5,939.52<0.01
Bank of America$3.78M1.07468,435-10.21%-$429,969.55<0.0001
Northern Trust$3.05M0.86377,761-1.19%-$36,565.17<0.0001
Panagora$3.01M0.85373,237+125.57%+$1.68M0.02
Nuveen$2.85M0.81353,1360%+$0<0.01
Charles Schwab$2.8M0.79346,953+4.72%+$126,214.81<0.01
Perkins Capital Management Inc$2.4M0.68297,949-0.56%-$13,442.112.09
Kennedy Capital Management Inc$2.38M0.68294,788-1.48%-$35,620.980.05
Oberweis Asset Management Inc$2.31M0.66286,400New+$2.31M0.17
Ameriprise Financial$2.23M0.63276,645-1.92%-$43,594.12<0.01
Kent Lake Capital LLC$1.62M0.46200,348New+$1.62M0.73
Goldman Sachs$1.55M0.44191,746-62.34%-$2.56M<0.0001
Connor Clark & Lunn Investment Management Ltd$1.55M0.44192,001+25.67%+$316,505.39<0.01
Birchview Capital Lp$1.4M0.4173,0000%+$00.08
Engineers Gate Manager Lp$1.3M0.37160,819+9.38%+$111,325.620.03
Rice Hall James & Associates, LLC$1.24M0.35153,174New+$1.24M0.07
BNY Mellon$1.19M0.34147,094-5.36%-$67,215.05<0.0001
Ubs Oconnor Llc$1.11M0.32137,5750%+$00.05
Legal & General$1.04M0.3129,302+24.2%+$203,291.34<0.0001
Cubist Systematic Strategies$962,154.000.27119,226+8.85%+$78,246.740.01
WHITE PINE CAPITAL, LLC$712,427.000.25111,143+3.17%+$21,858.110.27
Exchange Traded Concepts, LLC$860,617.000.24106,644+33.53%+$216,122.650.02
Divisadero Street Capital Management Lp$806,758.000.2399,970+117.47%+$435,788.120.19
Raymond James Financial Services Advisors Inc$748,573.000.2192,760+0.54%+$4,035.00<0.01
Renaissance Technologies$707,000.000.287,600-19.34%-$169,486.30<0.01
Keeley Teton Advisors Llc$683,731.000.1984,7250%+$00.09
Franklin Templeton Investments$526,463.000.1565,237New+$526,463.00<0.0001
M&T Bank$505,954.000.1462,690+10.41%+$47,698.01<0.01
Assenagon Asset Management S.A.$500,243.000.1461,9880%+$0<0.01
RhumbLine Advisers$442,041.000.1354,777+3.11%+$13,315.22<0.0001
Wells Fargo$405,800.000.1250,285+25.57%+$82,644.88<0.0001
AllianceBernstein$385,665.000.1147,7900%+$0<0.0001
American Century Investments$377,797.000.1146,815+176.98%+$241,397.88<0.0001
Roubaix Capital, LLC$350,577.000.143,442New+$350,577.000.22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.